Artiva Biotherapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(40.6%),Peter Kolchinsky(40.6%)等
Artiva Biotherapeutics | SC 13G:超过5%持股股东披露文件-venBio Global Strategic Fund III, L.P.(7.8%),venBio Global Strategic GP III, L.P.(7.8%)等
Artiva Biotherapeutics | SC 13G:超过5%持股股东披露文件-Andrew J. Schwab(10.1%),Kush Parmar(10.1%)等
Artiva Biotherapeutics | SC 13G:超过5%持股股东披露文件-Venrock Healthcare Capital Partners III, L.P.(6.9%),VHCP Co-Investment Holdings III, LLC(6.9%)等
Artiva Biotherapeutics | SC 13D:超过5%持股股东披露文件-RA Capital Management, L.P.(42.3%),Peter Kolchinsky(42.3%)等
Artiva Biotherapeutics | SC 13D:超过5%持股股东披露文件-GC Corp.(19.6%),Yong-Jun Huh(19.6%)等
Artiva Biotherapeutics | 4:持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.
Artiva Biotherapeutics | 4:持股变动声明-股东 5AM Partners VI, LLC
Artiva Biotherapeutics | 4:持股变动声明-股东 Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
Artiva Biotherapeutics | 4:持股变动声明-股东 venBio Global Strategic Fund III, L.P.
Artiva Biotherapeutics | 4:持股变动声明-股东 GC Corp.
Artiva Biotherapeutics | 4:持股变动声明-董事 Huh Yong-Jun
Artiva Biotherapeutics | 4:持股变动声明-高管 Aslan Fred
Artiva Biotherapeutics, Inc. | 3:首次持股声明-股东 venBio Global Strategic Fund III, L.P.
Artiva Biotherapeutics, Inc. | 3:首次持股声明-董事 RA CAPITAL MANAGEMENT, L.P.
Artiva Biotherapeutics, Inc. | 3:首次持股声明-股东 5AM Partners VI, LLC
Artiva Biotherapeutics, Inc. | 3:首次持股声明-董事 Miralles Gines Diego
Artiva Biotherapeutics, Inc. | 3:首次持股声明-股东 Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
Artiva Biotherapeutics, Inc. | 3:首次持股声明-董事 Stoppel Laura
Artiva Biotherapeutics, Inc. | 3:首次持股声明-董事 HOUGEN ELIZABETH L
暂无数据